Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Nektar Therapeutics
Information provided by (Responsible Party):
Lawrence Recht, Stanford University
ClinicalTrials.gov Identifier:
NCT01663012
First received: August 2, 2012
Last updated: September 18, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)